PROMEDIOR, INC.
9Patents
9Active
9Granted
48Portfolio score
Filing activity: Dec 4, 2007 → Oct 8, 2014 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8497243B2 | Methods and compositions useful in the treatment of mucositis | Chemistry; Metallurgy | 7 | Active |
| US9296800B2 | Serum amyloid P derivatives and their preparation and use | Human Necessities | 7 | Active |
| US8247370B2 | Conjoint therapy for treating fibrotic diseases | Emerging Cross-Sectional Technologies | 5 | Active |
| US8329659B2 | SAP variants and their use | Human Necessities | 5 | Active |
| US9233140B2 | Treatment methods for hypersensitive disorders | Human Necessities | 2 | Active |
| US10702583B2 | Treatment methods for autoimmune disorders | Emerging Cross-Sectional Technologies | 1 | Active |
| US9884899B2 | Methods for treating fibrosis using CRP antagonists | Physics | 1 | Active |
| US9556246B2 | SAP variants and their use | Human Necessities | 1 | Active |
| US11020451B2 | Methods for treating fibrotic cancers | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.